Comparative effectiveness without head-to-head trials: a method for matching-adjusted indirect comparisons applied to psoriasis treatment with adalimumab or etanercept.
- Published in:
- 2010
- By:
- Publication type:
- journal article
Works matching IS 11707690 AND DT 2010 AND VI 28 AND IP 10
Results: 28
1
2
Comparative effectiveness, personalized medicine and innovation: the path forward.
- Published in:
- 2010
- By:
- Publication type:
- journal article
3
Regulatory benefit-risk assessment and comparative effectiveness research: strangers, bedfellows or strange bedfellows?
- Published in:
- 2010
- By:
- Publication type:
- journal article
4
The economics of comparative effectiveness studies: societal and private perspectives and their implications for prioritizing public investments in comparative effectiveness research.
- Published in:
- 2010
- By:
- Publication type:
- journal article
5
Guiding comparative effectiveness research--a US perspective: an interview between Howard Birnbaum (of Analysis Group, Inc., and Guest Co-Editor of this Special Issue) and Jean R. Slutsky (Director, Center for Outcomes and Evidence, Agency for Healthcare Research and Quality). Interview by Howard Birnbaum.
- Published in:
- 2010
- By:
- Publication type:
- Interview
6
International comparison of comparative effectiveness research in five jurisdictions: insights for the US.
- Published in:
- 2010
- By:
- Publication type:
- journal article
7
Using comparative effectiveness research to inform policy and practice in the UK HHS: past, present and future.
- Published in:
- 2010
- By:
- Publication type:
- journal article
8
Perspectives on comparative effectiveness research: views from diverse constituencies.
- Published in:
- 2010
- By:
- Publication type:
- Editorial
9
Generating Evidence for Comparative Effectiveness Research Using More Pragmatic Randomized Controlled Trials.
- Published in:
- PharmacoEconomics, 2010, v. 28, n. 10, p. 969, doi. 10.2165/11536160-000000000-00000
- By:
- Publication type:
- Article
10
No Head-to-Head Trial? Simulate the Missing Arms.
- Published in:
- PharmacoEconomics, 2010, v. 28, n. 10, p. 957, doi. 10.2165/11537420-000000000-00000
- By:
- Publication type:
- Article
11
There's a Reason They Call Them Dummy Variables.
- Published in:
- PharmacoEconomics, 2010, v. 28, n. 10, p. 947, doi. 10.2165/11537750-000000000-00000
- By:
- Publication type:
- Article
12
Comparative Effectiveness Without Head-to-Head Trials.
- Published in:
- PharmacoEconomics, 2010, v. 28, n. 10, p. 935, doi. 10.2165/11538370-000000000-00000
- By:
- Publication type:
- Article
13
Managed Care Pharmacy Sees Potential of Comparative Effectiveness Research to Improve Patient Care and Lower Costs.
- Published in:
- PharmacoEconomics, 2010, v. 28, n. 10, p. 931, doi. 10.2165/11535610-000000000-00000
- By:
- Publication type:
- Article
14
Comparative Effectiveness, Personalized Medicine and Innovation.
- Published in:
- PharmacoEconomics, 2010, v. 28, n. 10, p. 923, doi. 10.2165/11539030-000000000-0000010.2165/11537370-000000000-00000
- By:
- Publication type:
- Article
15
Comparative Effectiveness Research.
- Published in:
- PharmacoEconomics, 2010, v. 28, n. 10, p. 915, doi. 10.2165/11535400-000000000-00000
- By:
- Publication type:
- Article
16
Comparative Effectiveness Research and Personalized Medicine.
- Published in:
- PharmacoEconomics, 2010, v. 28, n. 10, p. 905, doi. 10.2165/11535830-000000000-00000
- By:
- Publication type:
- Article
17
Comparative Effectiveness Research and the Psychology of Medical Practice.
- Published in:
- PharmacoEconomics, 2010, v. 28, n. 10, p. 899, doi. 10.2165/11535620-000000000-00000
- By:
- Publication type:
- Article
18
Perspective and Desire in Comparative Effectiveness Research.
- Published in:
- PharmacoEconomics, 2010, v. 28, n. 10, p. 889, doi. 10.2165/11535270-000000000-00000
- By:
- Publication type:
- Article
19
Comparative Effectiveness Regulations and Pharmaceutical Innovation.
- Published in:
- PharmacoEconomics, 2010, v. 28, n. 10, p. 877, doi. 10.2165/11537570-000000000-00000
- By:
- Publication type:
- Article
20
Cost-Effectiveness Analysis in Markets with High Fixed Costs.
- Published in:
- PharmacoEconomics, 2010, v. 28, n. 10, p. 867, doi. 10.2165/11535630-000000000-00000
- By:
- Publication type:
- Article
21
Regulatory Benefit-Risk Assessment and Comparative Effectiveness Research.
- Published in:
- PharmacoEconomics, 2010, v. 28, n. 10, p. 855, doi. 10.2165/11538640-000000000-00000
- By:
- Publication type:
- Article
22
The Economics of Comparative Effectiveness Studies.
- Published in:
- PharmacoEconomics, 2010, v. 28, n. 10, p. 843, doi. 10.2165/11539400-000000000-00000
- By:
- Publication type:
- Article
23
Guiding Comparative Effectiveness Research -- A US Perspective.
- Published in:
- 2010
- By:
- Publication type:
- Interview
24
Value-Based Approaches to Healthcare Systems and Pharmacoeconomics Requirements in Asia.
- Published in:
- PharmacoEconomics, 2010, v. 28, n. 10, p. 831, doi. 10.2165/11538360-000000000-00000
- By:
- Publication type:
- Article
25
International Comparison of Comparative Effectiveness Research in Five Jurisdictions.
- Published in:
- PharmacoEconomics, 2010, v. 28, n. 10, p. 813, doi. 10.2165/11536150-000000000-00000
- By:
- Publication type:
- Article
26
Using Comparative Effectiveness Research to Inform Policy and Practice in the UK NHS.
- Published in:
- PharmacoEconomics, 2010, v. 28, n. 10, p. 799, doi. 10.2165/11535260-000000000-00000
- By:
- Publication type:
- Article
27
Perspectives on Comparative Effectiveness Research Views from Diverse Constituencies.
- Published in:
- 2010
- By:
- Publication type:
- Editorial
28
Introducing Perspectives on Comparative Effectiveness Research.
- Published in:
- PharmacoEconomics, 2010, v. 28, n. 10, p. 787, doi. 10.2165/11535820-000000000-00000
- By:
- Publication type:
- Article